Xiaoting Chen

Xiaoting Chen

Auto-generated profile, based on publicly available information

Xiaoting Chen

Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Department of Endocrinology, Geriatric Medicine Center, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, People’s Republic of China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
MWMian Wu
Mian Wu
YMYiwen Ma
Yiwen Ma
XCXiaoting Chen
Xiaoting Chen
NLNan Liang
Nan Liang
SQShen Qu
Shen Qu
HCHaibing Chen
Haibing Chen
Epidemiological research has shown that elevated serum urate concentration is a risk factor for the development of kidney disease; however, the mechanisms underlying this process have not yet been elucidated. To examine the role of urate in the kidney, we used Wistar rats to functionally disrupt expression of urate oxidase (UOX) by using the CRISPR/Cas9 system. In comparison to wild-type (WT) rats, serum urate levels spontaneously and persistently increased in UOX-KO rats, without showing a significant decrease in survival rate. Architecture and function of the kidneys in UOX-KO rats were impaired. Injury to the kidney resulted in increased interstitial fibrosis, macrophage infiltration, increased expression of NLRP3 and IL-1β, and activation of multiple cell-signaling pathways associated with autophagy, such as AMPK, p38 MAPK, ERK and JNK pathways. Inhibition of autophagy with the PI3K inhibitor 3-MA abrogated the development of kidney damage and attenuated renal fibrosis, macrophage infiltration, and expression of NLRP3 and IL-1β in injured kidneys. In conclusion, the UOX-KO rat is a great model to study hyperuricemia-related diseases. Hyperuricemia-induced autophagy and NLRP3-dependent inflammation are critically involved in the development of renal damage and, therefore, highlight the inhibition of autophagy and inflammation in search of therapeutic strategies to treat uric acid nephropathy.

1 July 2026 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
XCXiaoting Chen
Xiaoting Chen
YWYangting Wang
Yangting Wang
CYChenyan Yan
Chenyan Yan
YHYingzi He
Yingzi He
YSYingxiang Song
Yingxiang Song
Purpose: Plasma proteins are associated with the onset and progression of osteoporosis (OP) and can serve as indicators for this disease. This study aimed to comprehensively analyze and identify plasma protein-associated biomarkers in OP, and clarify their potential molecular mechanisms. Methods: Data related to OP and plasma protein-associated genes were retrieved from public databases. Biomarkers were screened and validated via high-dimensional Weighted Gene Co-Expression Network Analysis (hdWGCNA), differential expression analysis, machine learning algorithms, and expression profiling. Additionally, nomogram construction, enrichment analysis, and immune infiltration analysis were performed to further investigate the regulatory roles of biomarkers. Molecular docking was conducted to computationally predict potential drug-target interactions, which require experimental verification. Single-cell RNA sequencing (scRNA-seq) data from one OP patient were used for exploratory examination of biomarker expression patterns in key cell types, providing cellular context for the bulk transcriptomic findings. Finally, reverse transcription quantitative polymerase chain reaction (RT-qPCR) validated biomarker expression in lymphocytes from 6 OP patients and 6 controls, while ELISA measured serum CTSD activity in 10 independent samples per group. Results: Two biomarkers (JUN and CTSD) were identified as significantly linked to plasma protein in OP. The nomogram developed based on these biomarkers showed potential diagnostic utility that warrants further evaluation. The biomarkers were significantly enriched in the ribosome, proteasome, lysosome, and spliceosome pathways. Notably, JUN showed strong positive correlations with activated dendritic cells and mast cells. Molecular docking further demonstrated that the biomarkers could bind favorably with streptozocin and bruceantin. Moreover, JUN and CTSD exhibited differential expression changes during the differentiation of bone marrow mesenchymal stem cells. Finally, we validated the expression of CTSD and JUN in lymphocytes from OP and control groups, finding that CTSD expression was increased in the OP group compared with the control group. Conclusion: In summary, we identified JUN and CTSD as transcriptome-derived plasma protein-associated gene biomarkers in OP. These findings may provide preliminary insights that could inform future diagnostic and therapeutic investigations, although further validation in larger cohorts and direct proteomic studies are warranted.